IL139588A0 - Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone - Google Patents

Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Info

Publication number
IL139588A0
IL139588A0 IL13958899A IL13958899A IL139588A0 IL 139588 A0 IL139588 A0 IL 139588A0 IL 13958899 A IL13958899 A IL 13958899A IL 13958899 A IL13958899 A IL 13958899A IL 139588 A0 IL139588 A0 IL 139588A0
Authority
IL
Israel
Prior art keywords
teerapeutic
combinations
estrogen receptor
parathyroid hormone
receptor modulator
Prior art date
Application number
IL13958899A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL139588A0 publication Critical patent/IL139588A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
IL13958899A 1998-06-16 1999-05-26 Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone IL139588A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8947998P 1998-06-16 1998-06-16
PCT/IB1999/000949 WO1999065482A1 (en) 1998-06-16 1999-05-26 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Publications (1)

Publication Number Publication Date
IL139588A0 true IL139588A0 (en) 2002-02-10

Family

ID=22217879

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13958899A IL139588A0 (en) 1998-06-16 1999-05-26 Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Country Status (34)

Country Link
US (1) US6132774A (es)
EP (1) EP1094808A1 (es)
JP (1) JP2002518323A (es)
KR (1) KR20010052818A (es)
CN (1) CN1305373A (es)
AP (1) AP9901580A0 (es)
AR (1) AR018867A1 (es)
AU (1) AU3725999A (es)
BG (1) BG105125A (es)
BR (1) BR9911228A (es)
CA (1) CA2335078A1 (es)
CO (1) CO5070584A1 (es)
EA (1) EA200001199A1 (es)
GT (1) GT199900066A (es)
HN (1) HN1999000063A (es)
HR (1) HRP20000858A2 (es)
HU (1) HUP0102759A3 (es)
ID (1) ID26873A (es)
IL (1) IL139588A0 (es)
IS (1) IS5719A (es)
MA (1) MA26649A1 (es)
NO (1) NO20006313D0 (es)
NZ (1) NZ508039A (es)
OA (1) OA11566A (es)
PA (1) PA8471201A1 (es)
PE (1) PE20000644A1 (es)
PL (1) PL344982A1 (es)
SK (1) SK18922000A3 (es)
TN (1) TNSN99119A1 (es)
TR (1) TR200003567T2 (es)
UA (1) UA60367C2 (es)
WO (1) WO1999065482A1 (es)
YU (1) YU75800A (es)
ZA (1) ZA993972B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
TW201043595A (en) * 2009-03-13 2010-12-16 Organon Nv Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de) 2010-07-09 2012-01-12 Universitätsklinikum Jena Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) * 2018-10-18 2020-04-28 常州大学 孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254595A (en) * 1988-12-23 1993-10-19 Elf Sanofi Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
TNSN99119A1 (fr) 2005-11-10
GT199900066A (es) 2000-10-31
ID26873A (id) 2001-02-15
AU3725999A (en) 2000-01-05
SK18922000A3 (sk) 2001-09-11
NO20006313L (no) 2000-12-12
EP1094808A1 (en) 2001-05-02
EA200001199A1 (ru) 2001-04-23
AP9901580A0 (en) 1999-06-30
AR018867A1 (es) 2001-12-12
BG105125A (en) 2001-11-30
IS5719A (is) 2000-11-21
PA8471201A1 (es) 2000-09-29
TR200003567T2 (tr) 2001-06-21
HUP0102759A2 (hu) 2002-03-28
BR9911228A (pt) 2001-02-13
HUP0102759A3 (en) 2002-12-28
CN1305373A (zh) 2001-07-25
NO20006313D0 (no) 2000-12-12
HN1999000063A (es) 2000-01-12
CO5070584A1 (es) 2001-08-28
OA11566A (en) 2004-05-26
CA2335078A1 (en) 1999-12-23
US6132774A (en) 2000-10-17
YU75800A (sh) 2003-12-31
KR20010052818A (ko) 2001-06-25
HRP20000858A2 (en) 2001-10-31
JP2002518323A (ja) 2002-06-25
UA60367C2 (uk) 2003-10-15
PL344982A1 (en) 2001-11-19
WO1999065482A1 (en) 1999-12-23
NZ508039A (en) 2003-03-28
PE20000644A1 (es) 2000-08-02
ZA993972B (en) 2000-12-15
MA26649A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
IL185087A0 (en) Selective estrogen receptor modulator in combination with a sex steroid precursor
GB9800854D0 (en) A material and device for terminal transaction
IL137035A0 (en) Method and device for configuring a link
IL149990A0 (en) Selective estrogen receptor modulators in combination with estrogens
IL139588A0 (en) Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
GB2331945B (en) Device for arresting a shaft
GB9907893D0 (en) System,device,and method for scheduling in a communication system
GB9828537D0 (en) A radio device
IL136457A0 (en) System and procedure for directing a short message
GB9719100D0 (en) A pre-payable communication device
GB2329098B (en) A mixing and dispensing apparatus
GB9715250D0 (en) A material and device for terminal printing
GB2346100B (en) Device for arresting a shaft
HUP0002779A3 (en) Method for transferring a bi-directional radio link and corresponding device
GB9706995D0 (en) A device
GB9819249D0 (en) A pointing device
GB2339983B (en) A modulator
PL345534A1 (en) Method and device for automatically switching a mortar gun on and off
TW337728U (en) A transverse mixer system
GB2315726B (en) A mixing device
GB9806032D0 (en) Estrogen receptor
GB9705765D0 (en) A location device and a method using same
GB2325247B (en) A follow-down device
ZA9811639B (en) A dosing device
GB9803603D0 (en) A carrying aid device